Corient Private Wealth LP Acquires New Holdings in Cigna Group $CI

Corient Private Wealth LP bought a new position in Cigna Group (NYSE:CI) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 554,756 shares of the health services provider’s stock, valued at approximately $40,315,000. Corient Private Wealth LP owned approximately 0.21% of Cigna Group at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. Perennial Investment Advisors LLC bought a new stake in Cigna Group during the second quarter valued at $279,000. Philadelphia Investment Partners LLC bought a new position in Cigna Group in the 2nd quarter worth about $330,000. Pingora Partners LLC purchased a new stake in shares of Cigna Group in the 2nd quarter valued at about $331,000. Ausdal Financial Partners Inc. purchased a new stake in shares of Cigna Group in the 2nd quarter valued at about $200,000. Finally, Bank of America Corp DE bought a new stake in shares of Cigna Group during the 2nd quarter valued at about $827,692,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Price Performance

CI opened at $277.21 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. The stock’s 50 day simple moving average is $283.53 and its 200 day simple moving average is $281.41. The firm has a market cap of $73.25 billion, a price-to-earnings ratio of 11.47, a PEG ratio of 0.97 and a beta of 0.29. Cigna Group has a 1 year low of $239.51 and a 1 year high of $315.47.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, July 30th. The health services provider reported $7.78 earnings per share for the quarter, beating the consensus estimate of $7.60 by $0.18. The firm had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.The business’s revenue was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, analysts predict that Cigna Group will post 30.51 earnings per share for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Tuesday, September 8th. Cigna Group’s dividend payout ratio is currently 25.82%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the sale, the insider owned 25,880 shares of the company’s stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 23,012 shares of company stock valued at $6,386,550 over the last quarter. 0.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CI shares. The Goldman Sachs Group upped their price objective on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Royal Bank Of Canada lifted their target price on shares of Cigna Group from $333.00 to $337.00 and gave the company an “outperform” rating in a research report on Friday, May 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. Piper Sandler lowered their price objective on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research report on Wednesday, June 3rd. Finally, UBS Group lifted their price target on Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, May 22nd. Fifteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Cigna Group has a consensus rating of “Moderate Buy” and a consensus price target of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.